Case Report: A case of interstitial pneumonia in a colorectal cancer patient with a history of lung cancer treated with cetuximab
The incidence of cetuximab-induced ILD is low and relatively rare, with non-specific clinical symptoms. Clinically, treatment plans should be tailored to the patient's actual condition to control disease progression and improve patient prognosis.
Authors
- Daoqun Chong
- Mei Ren (ORCID: https://orcid.org/0000-0003-0696-0945)
- Hongjun Li
- Qingqing Yu (ORCID: https://orcid.org/0000-0001-5104-0502)
- Bin Zhang (ORCID: https://orcid.org/0000-0001-9903-083X)
- Yang Yang (ORCID: https://orcid.org/0000-0002-1755-2640)
- Haibo Zhao (ORCID: https://orcid.org/0009-0007-8865-0532)
- Yujin Guo
Institutions
- Jining First People's Hospital (CN)
- Jining Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.3389/fonc.2025.1541649
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00